THE GDC has issued guidance confirming that remote prescribing should not be used in the provision of non-surgical cosmetic procedures such as the prescription or administration of Botox or injectable cosmetic medicinal products.
In a statement on its website the GDC expressed concern that some registrants may be using remote prescribing inappropriately. The Independent Healthcare Advisory Service (IHAS) was recently made aware for the first time of a dentist who is believed to be prescribing Botox remotely. IHAS was set up with the backing of the previous government to set standards for the provision of injectable cosmetics and to run a voluntary register of providers.
Both the General Medical Council and the Nursing and Midwifery Council have experience of their registrants either prescribing, or treating patients with, remotely prescribed Botox and other cosmetic injectables and the regulators have issued guidance making it clear the practice is unacceptable. Consultations on the topic have referred explicitly to remote prescription and supply of Botox for administration by nurses and beauty therapists.
The GDC policy is intended to bring consistency with other healthcare regulators in this area.